Evidence map›Paper›PMID 31450232›Full record

ArticlePediatric research2020

Molecular findings in children with inherited intrahepatic cholestasis.

Neng-Li Wang, Yi Lu, Jing-Yu Gong, Xin-Bao Xie, Jing Lin, Kuerbanjiang Abuduxikuer, Mei-Hong Zhang, Jian-She Wang

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Pediatric research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 19 citations in OpenAlex.

  1. [Analysis of the etiology and clinical indicators of infantile cholestasis].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2024
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. [Concern about liver disease in children].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Neng-Li WangThe Center for Pediatric Liver Diseases, Children's Hospital of Fudan University, Shanghai, China.
Yi LuThe Center for Pediatric Liver Diseases, Children's Hospital of Fudan University, Shanghai, China.
Jing-Yu GongDepartment of Pediatrics, Jinshan Hospital of Fudan University, Shanghai, China.
Xin-Bao XieThe Center for Pediatric Liver Diseases, Children's Hospital of Fudan University, Shanghai, China.
Jing LinDepartment of Pediatrics, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Kuerbanjiang AbuduxikuerThe Center for Pediatric Liver Diseases, Children's Hospital of Fudan University, Shanghai, China.
Mei-Hong ZhangDepartment of Pediatrics, Jinshan Hospital of Fudan University, Shanghai, China.
Jian-She WangThe Center for Pediatric Liver Diseases, Children's Hospital of Fudan University, Shanghai, China. jshwang@shmu.edu.cn.
Children's Hospital of Fudan University · CNJinshan Hospital of Fudan University · CNIcahn School of Medicine at Mount Sinai · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGenetic defects account for a substantial proportion of pediatric cholestasis. This study explored the molecular findings in a large cohort of Chinese patients with inherited cholestasis.

methodsBetween January 2012 and June 2016, 809 Chinese pediatric patients with suspected inherited intrahepatic cholestasis were evaluated by Sanger sequencing and/or panel sequencing.

resultsOf the 809 patients, 273 (33.7%) obtained a genetic diagnosis. The rate of positive genetic diagnosis in patients with disease onset at 0-3 month of age was higher than that in patients with disease onset at 4 month of age or later. There were 17 distinct genetic defects diagnosed. The top 4 resulted from mutations in SLC25A13 (44.3%), JAG1 (24.5%), ABCB11 (11.0%), and ATP8B1 (5.9%). All 17 genetic disorders were diagnosed in patients with disease onset at 0-3 months of age; but only 5 were diagnosed in patients with disease onset beyond 4 months of age. A total of 217 distinct pathogenic variants, including 41 novel variants, were identified. Ten recurrent mutations were detected in SLC25A13, ATP8B1, and CYP27A1. They accounted for 48.2% of the total 477 mutant alleles.

conclusionsThere were 17 distinct genetic disorders diagnosed in Chinese pediatric patients with inherited cholestasis.

Indexed as

MutationAdenosine TriphosphatasesAdolescentAsian PeopleATP Binding Cassette Transporter, Subfamily B, Member 11ChildChild, PreschoolChinaCholestanetriol 26-MonooxygenaseCholestasis, IntrahepaticFemaleGenetic Predisposition to DiseaseHeredityHumansInfantJagged-1 ProteinABCB11 protein, humanAdenosine TriphosphatasesATP8B1 protein, humanATP Binding Cassette Transporter, Subfamily B, Member 11Cholestanetriol 26-MonooxygenaseCYP27A1 protein, humanJAG1 protein, humanJagged-1 ProteinMitochondrial Membrane Transport ProteinsSLC25A13 protein, human

Identifiers

PMID31450232
OpenAlexW2970896839

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.